News

Test for Deadly Lung Disease Is Used for First Time in Texas – Anoop Nambiar, MD

Anoop Nambiar, MD

A UT Health San Antonio lung specialist is the first in Texas to use a new genomic test to better and less invasively diagnose a patient with idiopathic pulmonary fibrosis (IPF), a serious, chronic, progressive and scarring lung disease with an average survival time of less than five years after diagnosis…….Read more>>>>   Source: MD […]

Read more

Wear The Gown: Managing the rare disease of cystic fibrosis

SAN ANTONIO — There are 70,000 people in the world with cystic fibrosis. 30,000 of them are here in the U.S. In this Wear The Gown, we take you into the only “CF” clinic in San Antonio that takes care of patients from birth, all the way into adulthood. “Cystic fibrosis is a genetic disease […]

Read more

Medical News Today: Can we halt cellular aging? New drug combo shows promise

The story below features research Anoop Nambiar, M.D., M.S., on a new class of drugs called senolytics that were studied in relation to idiopathic pulmonary fibrosis. Dr. Nambiar is a professor of medicine and founding director of the Interstitial Lung Disease Program at UT Health San Antonio. Two other faculty members are mentioned in the […]

Read more

Woman beats potentially deadly disease after life-saving suggestion on social media

SAN ANTONIO — A local woman nearly lost her battle with a rare lung disease because it had gone undiagnosed. But it was her persistence to get help ultimately saved her life. Angela Michelle Ramos has a new lease on life. She’s working out and getting in shape; something that, until now, was out of […]

Read more

First-in-human trial of senolytic drugs encouraging

Small pilot study points to feasibility of larger trials in age-related diseases UT Health San Antonio researchers, collaborating with the Mayo Clinic and the Wake Forest School of Medicine, are the first to publish results on the treatment of a deadly age-related disease in human patients with drugs called senolytics. The findings were posted Jan. […]

Read more

Research update: New test for pulmonary fibrosis

A UT Health San Antonio lung specialist is the first in Texas to use a new genomic test to better and less invasively diagnose a patient with idiopathic pulmonary fibrosis (IPF), a serious chronic, progressive and scarring lung disease with an average survival time of less than five years after diagnosis.

Read more

Biomarkers in COPD

The role of biomarkers in chronic obstructive pulmonary disease (COPD) are still riddled with unknowns, but Antonio R. Anzueto, MD, of UT Health San Antonio, is working to further define their function and role in the disease. Read more online.

Read more

Partnership leads to improved lifelong care center

“Holly Keyt, MD, who heads the adult CF program, notes that there now are more adults than children surviving with CF in this country — which represents a major shift. “We’re making huge leaps and bounds in terms of survival and improvement of quality of life for people with CF,” says Dr. Keyt, a pulmonologist […]

Read more

Faculty member to lead American College of Chest Physicians

Stephanie M. Levine, M.D., professor of the Department of Medicine’s Division of Pulmonary Diseases and Critical Care Medicine, will become only the fifth woman to serve as president of the American College of Chest Physicians in the past 80 years. Dr. Levine is director of the Pulmonary/Critical Care Fellowship Program and director of the VA […]

Read more

Congratulations to Dr. Sandra G. Adams for receiving a Physicians Initiated Interprofessional Grant

Sandra G. Adams, MD, MS is a Professor of Medicine in the Pulmonary/Critical Care Division of UT Health in San Antonio, Texas and Staff Physician at The South Texas Veterans Health Care System. Dr. Adams is an internationally recognized leader and educator in Chronic Obstructive Pulmonary Disease (COPD), asthma, and the chronic care model. Dr. Adams received […]

Read more